Earnings Call · Q2 FY2026·2026-08-04

Q2 26EPS n/a·Rev n/aQ1 26EPS -5.48%·Rev n/aQ4 25EPS -10.26%·Rev n/aQ3 25EPS -49.59%·Rev n/a⚠ consensus missing

Ultragenyx Pharmaceutical Inc. RARE

Joshua Higa — Chief of Staff and Vice President of Investor Relations

Emil Kakkis — Chief Executive Officer and President

Erik Harris — Chief Commercial Officer

Howard Horn — Chief Financial Officer

Erik Crombez — Chief Medical Officer

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RARE calls or request research access.

More RARE calls Browse calls Request research access